| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 09/28/2006 | US20060217358 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/26/2006 | US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/21/2006 | WO2006097342A1 Process for making steroidal compounds |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/21/2006 | US20060211670 Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates |
| 09/21/2006 | US20060210554 Detection of cholesterol ozonation products |
| 09/20/2006 | EP1497308B1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 09/19/2006 | US7109360 16 alpha - and 16 beta -hydroxy-estra-1,3,5(10)-estratrienes, which carry additional substituents on the steroid skeleton and can have one or more additional double bonds in the B-, C- and/or D-rings; higher affinity to estrogen receptors from rat prostates than to estrogen receptors from rat uteri |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/19/2006 | CA2248186C Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/07/2006 | US20060198836 Method of treating hit patients with argatroban |
| 09/06/2006 | EP1525215B1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 08/31/2006 | WO2006072599A3 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 08/31/2006 | WO2006003013B1 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 08/31/2006 | WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/30/2006 | EP1147124B1 Steroid sulfatase inhibitors and methods for making and using the same |
| 08/29/2006 | US7098199 Administering a polycyclic sulfamate ester that is replaced with a sulfate group and incubated with a seroid sulphatase enzyme at 7.4 pH and 37 degrees C to provide a Km value of < 50 micrometers |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/23/2006 | EP1339734B1 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 08/23/2006 | CN1821263A Intermediates for 16 beta -methyl steroids |
| 08/22/2006 | CA2328085C Solid dispersion containing sialic acid derivative |
| 08/17/2006 | US20060183928 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 08/10/2006 | WO2006082126A1 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same |
| 08/10/2006 | CA2601724A1 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same |
| 08/08/2006 | US7087591 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/02/2006 | CN1812767A Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations |
| 08/01/2006 | CA2341263C Enzyme inhibition immunoassay |
| 08/01/2006 | CA2191397C Method for the preparation of steroid derivative ketal |
| 07/27/2006 | US20060166950 Treatment of neovascularization disorders with squalamine |
| 07/26/2006 | EP1082338B1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/26/2006 | CN1266192C Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display |
| 07/20/2006 | US20060160782 2-Substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 07/20/2006 | US20060160781 A conjugated compound with triamcinolone acetonide; Antiinflammatory agents; immunosuppressants |
| 07/20/2006 | US20060160780 A conjugated compound with prednicarbate; Antiinflammatory agents; immunosuppressants |
| 07/19/2006 | EP1680441A1 Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | CN1805970A Process for the synthesis of high purity D-(17alpha)-13-ethyl-17 -hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 07/18/2006 | US7078396 Method of treating disorder related to high cholesterol concentration |
| 07/13/2006 | WO2006072600A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 07/13/2006 | WO2006072599A2 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/13/2006 | US20060154985 For therapy of prostate cancer |
| 07/13/2006 | US20060154905 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/12/2006 | EP1496865B1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/05/2006 | CN1798758A Pure d-(17 alpha)-13-ethyl -17-hydroxy-18, 19-dinorpregn-4- ene-20- yne-3-one -3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 06/27/2006 | US7067683 Industrially applicable process for the sulfamoylation of alcohols and phenols |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/27/2006 | US7067504 Di-steroidal prodrugs of ethinyl estradiol |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067326 Binding particle for use in the biosynthesis and separation of particles in sample |
| 06/22/2006 | WO2006003013A3 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 06/22/2006 | US20060135796 Antiangiogenic agents |
| 06/21/2006 | EP0923600B1 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/21/2006 | CN1791611A 17beta-hydroxysteroid dehydrogenase inhibitors. |
| 06/21/2006 | CN1791610A Oestrogen derivatives as inhibitors of steroid sulphatase. |
| 06/21/2006 | CN1259918C Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2006 | US7064116 GABAA modulating neurosteroids |
| 06/14/2006 | EP1669366A1 Lipids comprising an aminoxy group |
| 06/14/2006 | EP1668026A1 Detection of cholesterol ozonation products |
| 06/06/2006 | US7056905 Antiinflammatory agents; immunosuppressants |
| 06/01/2006 | WO2006034369A3 Sulfated molecular umbrellas containing 6-200 cholanic acid (derivative) units as anti-hiv and anti-hsv agents |
| 05/30/2006 | US7053229 Process for the production of 4-(17α-alkoxymethyl-17β-substituted 3-oxoestra-4,9-dien-11β-yl) benzaldehyde-(1E)-oxime derivatives |
| 05/30/2006 | US7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/10/2006 | CN1255425C Process and intermediates for production of 7-substituted antiestrogens |
| 05/04/2006 | WO2006015081A3 A PROCESS FOR THE PREPARATION OF 7α-ALKYLATED 19-NORSTEROIDS |
| 05/04/2006 | US20060094696 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 05/04/2006 | US20060094664 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 04/26/2006 | EP1648232A2 Method of treating hit patients with argatroban |
| 04/19/2006 | EP1051177B1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 04/19/2006 | CN1252081C Intermediate for preparation of 16 Beta-methyl steroids |
| 04/18/2006 | CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates |
| 04/06/2006 | US20060074060 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer |
| 04/05/2006 | EP1641812A1 PURE D-(17a)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS |
| 03/30/2006 | WO2006034369A2 Sulfated molecular umbrellas containing 6-200 cholanic acid (derivative) units as anti-hiv and anti-hsv agents |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/29/2006 | EP1638988A1 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 03/29/2006 | CN1753905A Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 03/28/2006 | US7018995 Carbonate and carbamate modified forms of glucocorticoids |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018993 Androstane derivatives having various substituents at positions 7 and/or 11, a prophylactic or therapeutic agent for a disease selected from prostate cancer, benign prostatic hyperplasia, alopecia, acne, precocioous puberty |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | US20060063749 immunomoderators ; bromo-3-hydroxyandrostan-17-one; antiallergens; rhinitis |
| 03/22/2006 | CN1751061A Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751060A Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751059A 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2062792C Treatment of androgen-related diseases |
| 03/16/2006 | WO2005116047A3 2-substituted 17-imino estrogen compounds for cytoprotection |